# Ery-Ped

NDC: 24338-130
Generic name: Erythromycin Ethylsuccinate
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20120614

FDA application: NDA050207

## Active ingredients

- ERYTHROMYCIN ETHYLSUCCINATE: 400 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-130"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-130
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04775721-ab87-4b66-808c-d67a21032385